Navigation Links
WET-FIELD Diathermy Coagulator (universal power supply for 100-240 volts) w/footswitch - electrically powered

ProductsWET-FIELD Diathermy Coagulator (universal power supply for 100-240 volts) w/footswitch - electrically powered
Company Medtronic Xomed, Inc.
Item WET-FIELD Diathermy Coagulator (universal power supply for 100-240 volts) w/footswitch - electrically powered
Features Inquire
Description The Wet-Field Coagulator provides precise episcleral, intrascleral, and intraocular hemostasis with reduced peripheral tissue trauma. Controlled Rf diathermy delivers targeted coagulation with the most comprehensive line of bipolar Eraser instruments, forceps and cables. This instrument combines enhanced features that ensure a high level of Wet-Field safety and operational effiiciency.
Info Medtronic Xomed, Inc.
Customer Service: (800) 874-5797
Web site: http://www.xomed.com/

Related medicine products :

1. WET-FIELD Diathermy Coagulator w/Harmonized Power Cord (universal power supply for 100-240 volts) and footswitch - electrically powered
2. Bipolar Coagulator
3. e-power Power Supply
4. QuantiFIRE 4-Megapixel Thermoelectrically-Cooled Digital Microscope Camera
Single piece PMMA lens, AC depth: 4.7.
Single-Piece PMMA IOLs for the replacement of the human crystalline lens in the visual correction of aphakia.
Single-Piece PMMA IOLs for the replacement of the human crystalline lens in the visual correction of aphakia.
An injectable IOL, single-use injector for the IOL and post-op protective eye-shield all packaged in one handy, ready-to-use system pack.
Medicine Products:
(Date:9/8/2008)... and Lead the Fight Against Ovarian ...wswire/ -- More than 30 years ago, L,Oreal Paris,c...te a woman,s worth and,self-esteem. In 1997, as an...raising money and awareness in the fight against o... Paris has offered hope to the tens of,thousands o...
(Date:9/8/2008)...to a mechanism whereby chemotherapy may actually a.... The research, published by Cell Press in the Sep...lps to explain why a combination of traditional ch...blood vessels might impede the devastating tumor r...emotherapy remains the most commonly employed form...
(Date:9/8/2008)...rd School of Public Health (HSPH) and their collab...r Institute (NCI) have identified a common genetic...gesting a new way to approach the biological conne...nd deficiency-related diseases. , "The news here... vitamin B12 levels," said David Hunter, the Vince...
(Date:9/8/2008)...ently reported on the risk of bone fractures among... The drugs are used to treat and reduce gastric ac...estinal issues including ulcers, gastroesophageal ...omach infections and Zollinger-Ellison Syndrome. ...mber 8, 2008 -- LegalView, the number one resource...
Breaking Medicine News(10 mins):Health News:L'Oreal Paris Continues Passionate Commitment to Ovarian Cancer Research and Awareness Programs in 2008 2Health News:L'Oreal Paris Continues Passionate Commitment to Ovarian Cancer Research and Awareness Programs in 2008 3Health News:L'Oreal Paris Continues Passionate Commitment to Ovarian Cancer Research and Awareness Programs in 2008 4Health News:Anti-angiogenic drugs impede chemotherapy-stimulated tumor recovery 2Health News:Genetic variants associated with vitamin B12 2Health News:Genetic variants associated with vitamin B12 3Health News:LegalView Warns Proton Pump Inhibitor Patients of Potential Bone Fracture Risk Associated with Drug 2Health News:LegalView Warns Proton Pump Inhibitor Patients of Potential Bone Fracture Risk Associated with Drug 3Health News:LegalView Warns Proton Pump Inhibitor Patients of Potential Bone Fracture Risk Associated with Drug 4
...d the first two head-to-head clinical trials that ...alendronate) once weekly 70mg and Actonel (risedro...bisphosphonates indicated for the treatment of ost...ed by Aventis and Procter & Gamble through the All...
...the Harvard School of Public Health now reveals th...h risks. They have found that women who care for a...coronary heart disease. The findings were reported...had collected data on caregiving and coronary hear...
... specialties, recently joined hands to demonstrate...ents. Dr. Peter Costantino, an otolaryngologist, a... tumor in Angela Carrozza’s nasal cavity and right... Clinical Oncology, nearly 38,000 cases of head an...
... long-awaiting new options in treatment, now have ... approval of the new drug, Amevive. This unique d...to-treat psoriasis. Psoriasis has been thought to ...called memory effector T cells prompt skin inflamm...
Other Medicine News:Health News:New and unique treatment for Psoriasis patients 2
(Date:9/8/2008)...Sept. 8 /- Medarex, Inc.,(N...milestone payment for an,undisclosed amount from i...his payment is a result of the submission of an In... for the clinical development of an antibody,gener...ay receive future,milestone payments and royalties...
(Date:9/8/2008)...Newswire-FirstCall/ -- Novo Nordisk (NYSE: NVO ),...a phase 3 clinical study,(LEAD(TM) 4) today at the...or the Study of Diabetes that demonstrated adding ...GLP-1 analog, to metformin and rosiglitazone in,th...blood glucose lowering,(HbA1c), weight loss, blood...
(Date:9/6/2008)...ing 95 Percent or Greater Concordance Compared to ... Breast -, - Company to Include Reporting for HER2... Reports by End of 2008 -, REDWOOD CITY, ...Health,Inc. (Nasdaq: GHDX ) today announced resu...ve reporting for HER2 gene expression, as measured...
(Date:9/5/2008)...ept. 5 /- When Michigan,s first chron...il deer at a deer farm in,Kent County, state and f...r,on the farmer,s property and began the process o...issuing the following statement on the negative CW... County Farm., The deer farm industry today recei...
Breaking Medicine Technology:Medarex Receives Milestone Payment from Pfizer for Investigational New Drug Application Filing 2Medarex Receives Milestone Payment from Pfizer for Investigational New Drug Application Filing 3Novo Nordisk New Data From a Phase 3 Study Confirms Clinical Benefits of Once-Daily Liraglutide in the Management of Type 2 Diabetes 2Novo Nordisk New Data From a Phase 3 Study Confirms Clinical Benefits of Once-Daily Liraglutide in the Management of Type 2 Diabetes 3Novo Nordisk New Data From a Phase 3 Study Confirms Clinical Benefits of Once-Daily Liraglutide in the Management of Type 2 Diabetes 4Novo Nordisk New Data From a Phase 3 Study Confirms Clinical Benefits of Once-Daily Liraglutide in the Management of Type 2 Diabetes 5Genomic Health Announces Data Supporting Use of Oncotype DX(R) to Accurately Assess HER2 Gene Expression in Breast Cancer Patients 2Genomic Health Announces Data Supporting Use of Oncotype DX(R) to Accurately Assess HER2 Gene Expression in Breast Cancer Patients 3Genomic Health Announces Data Supporting Use of Oncotype DX(R) to Accurately Assess HER2 Gene Expression in Breast Cancer Patients 4Genomic Health Announces Data Supporting Use of Oncotype DX(R) to Accurately Assess HER2 Gene Expression in Breast Cancer Patients 5Deer Farm Industry in Michigan Issues Statement on the Negative CWD Test Results at Kent County Deer Farm 2Deer Farm Industry in Michigan Issues Statement on the Negative CWD Test Results at Kent County Deer Farm 3New gas sensors for monitoring carbon dioxide sinks 3234 1New gas sensors for monitoring carbon dioxide sinks 3234 2Dr Arnold Klein Warns of Dangers With Permanent and Longer Lasting Injectable Fillers 18794 1Dr Arnold Klein Warns of Dangers With Permanent and Longer Lasting Injectable Fillers 18794 2The HealthCentral Network Signs Spunky Midlife Gals for Comedic Relief on Alzheimers Skin Care Sites 18790 1The HealthCentral Network Signs Spunky Midlife Gals for Comedic Relief on Alzheimers Skin Care Sites 18790 2GSKs Ernestine Harris Honored as Industry Rising Star by Healthcare Businesswomens Association 18786 1GSKs Ernestine Harris Honored as Industry Rising Star by Healthcare Businesswomens Association 18786 2GSKs Ernestine Harris Honored as Industry Rising Star by Healthcare Businesswomens Association 18786 3
...LADELPHIA, July 3, 2007-- One of the fundamental t...system – might become,its greatest vulnerabi... of Southern California. Their findings,demonstr...ate that,a technique for determining a tumor&rsquo... for diagnosing and treating,specific cancers. , ...
...ROUCK HEIGHTS, N.J.--(BUSINESS WIRE)--Jul 3, 2007 ...today announced that,further clinical results from...atic hyperplasia (BPH) will be presented at the Ne...iation Meeting in,Boston in September. The paper i...ors from U.S. clinical trials of NX-107., The Comp...
Other Medicine Technology:Researchers Discover Method for Identifying How Cancer Evades the,Immune System 2Researchers Discover Method for Identifying How Cancer Evades the,Immune System 3Clinical Data From Nymox BPH Drug To Be Presented at American,Urological Association Meeting 2